Dipna Pharmachem shareholders and shareholding pattern
BSE: 543594Pharmaceuticals & BiotechnologySmall Cap
DIPNA PHARMACHEM LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2022
Last close ₹3.76down ₹0.03 (0.79%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹3.79.
28 Oct: open ₹3.79, high ₹3.79, low ₹3.70
52-week range of traded prices to 28 Oct 2026
₹3.70Low, 28 Oct 2026₹20.50High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9.88 Cr3,953rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 54,000
Dipna Pharmachem's shareholding pattern for Sep 2026, filed on 21 Oct 2026, with every filing from Mar 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Dipna Pharmachem, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters9.13%
- Individuals and others90.87%
Shareholding pattern, per cent
- Promoters
- Individuals and others
| Per cent | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| 9.13% | 9.13% | 9.13% | |
| Indian promoters | 9.13% | 9.13% | 9.13% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 90.87% | 90.87% | 90.87% |
| Shares in issue | 2,62,89,250 | 2,62,89,250 | 2,62,89,250 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 55,76,500 | 22,44,000 | – |
| Promoters' shares locked in | 23,99,500 | – | – |
A dash is a line the filing did not state.
Dipna Pharmachem promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Keyur Dipakkumar Shah, 9.12%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Keyur Dipakkumar ShahIndividuals and Hindu undivided families | 9.12% | 23,97,000 |
| Dipna Keyur ShahIndividuals and Hindu undivided families | 0.01% | 2,500 |
| Dhara Nrupeshbhai ShahIndividuals and Hindu undivided families | 0.00% | 100 |
| Chaitanya Chinubhai NanavatiIndividuals and Hindu undivided families | 0.00% | 100 |
No promoter shares are reported as pledged.
Largest public holders of Dipna Pharmachem, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| KAJAL ASHOK JAINResident individuals, over ₹2 lakh at face value | 4.28% | 4.28% | 4.28% |
| ASHOK DILIPKUMAR JAINResident individuals, over ₹2 lakh at face value | 4.26% | 4.26% | 4.26% |
| SIDDHARTH PODDARResident individuals, over ₹2 lakh at face value | 4.11% | 4.11% | 4.11% |
| TEENA KIRTI JAINResident individuals, over ₹2 lakh at face value | 3.75% | 3.26% | 3.26% |
| VIBHA R TRIPATHIResident individuals, over ₹2 lakh at face value | 2.62% | 2.62% | 2.58% |
| GIRISH GANESH SATHEResident individuals, over ₹2 lakh at face value | 1.94% | 1.94% | 2.19% |
| MAHESHBHAI JIVANBHAI RAMANIResident individuals, over ₹2 lakh at face value | 2.19% | 2.19% | 2.19% |
| SUNITA SANTOSH GOENKAResident individuals, over ₹2 lakh at face value | 1.83% | 1.83% | 1.83% |
| Kaavya AgrawalResident individuals, over ₹2 lakh at face value | – | 1.04% | 1.67% |
| RAVI BHUSHAN PURIResident individuals, over ₹2 lakh at face value | 1.14% | 1.18% | 1.60% |
| ALKA JAYSING TAMBEResident individuals, over ₹2 lakh at face value | 1.57% | 1.57% | 1.57% |
| JANHAVI SANTOSH GHADGEResident individuals, over ₹2 lakh at face value | 1.48% | 1.48% | 1.48% |
| BAGESHRI SANTOSH KANITKARNon-resident Indians | 1.42% | 1.42% | 1.42% |
| FALGUNI YOGENDRA TRIVEDIResident individuals, over ₹2 lakh at face value | – | 1.14% | 1.14% |
| SANJAY NIRMAL JAIN HUFOther non-institutions | 2.50% | 2.43% | 1.13% |
| NARESHKUMAR KAPOORCHAND JAINResident individuals, over ₹2 lakh at face value | 1.11% | 1.11% | 1.11% |
| Namita Hemant JainResident individuals, over ₹2 lakh at face value | 4.21% | 3.59% | – |
| Neerita Sanjay jainResident individuals, over ₹2 lakh at face value | 2.23% | 2.19% | – |
| Rajesh TripathiResident individuals, over ₹2 lakh at face value | 1.77% | 1.81% | – |
| HEMANT NARESH JAIN HUFOther non-institutions | 3.02% | – | – |
| VIHA ASHOK JAINResident individuals, over ₹2 lakh at face value | 1.05% | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: Namita Hemant Jain no longer named, from 3.59%; Neerita Sanjay jain no longer named, from 2.19%; Rajesh Tripathi no longer named, from 1.81%; 5 more moved